Evidence map›Paper›PMID 32356172›Full record

ArticleMolecular neurobiology2020

Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation.

Andrea Comella-Bolla, Javier G Orlandi, Andrés Miguez, Marco Straccia, María García-Bravo, Georgina Bombau, Mireia Galofré, Phil Sanders, Jordi Carrere, José Carlos Segovia and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatum.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Merits and challenges of iPSC-derived organoids for clinical applications.Frontiers in cell and developmental biology · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. From Progenitors to Progeny: Shaping Striatal Circuit Development and Function.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Andrea Comella-BollaLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9480-5050
Javier G OrlandiPathophysiology of Neurodegenerative Disease. Laboratory, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5683-1717
Andrés MiguezLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-6014-3685
Marco StracciaLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-3903-4163
María García-BravoDifferentiation and Cytometry Unit, Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.ORCID https://orcid.org/0000-0002-1890-1064
Georgina BombauLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.
Mireia GalofréLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-1863-619X
Phil SandersLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5658-8400
Jordi CarrereLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5480-6072
José Carlos SegoviaDifferentiation and Cytometry Unit, Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIEMAT/CIBERER), Madrid, Spain.ORCID https://orcid.org/0000-0003-4101-6124
Joan BlasiLaboratory of Cellular and Molecular Neurobiology, Department Pathology and Experimental Therapeutics, Faculty of Medicine and Health Science, Biomedical Research Institute of Bellvitge (IDIBELL), University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-0482-9444
Nicholas D AllenCardiff Repair Group, School of Biosciences and medicine, Cardiff University, Cardiff, Wales, UK.
Jordi AlberchProduction and validation center of advanced therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-8684-2721
Jordi SorianoDepartament de Física de la Matèria Condensada, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2676-815X
Josep M CanalsLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain. jmcanals@ub.edu.ORCID https://orcid.org/0000-0001-6829-7670
Biomedical Research Networking Center on Neurodegenerative Diseases · ESCentre for Biomedical Network Research on Rare Diseases · ESCardiff University · GBInstitut d'Investigació Biomédica de Bellvitge · ESNeurosciences Institute · USUniversitat de Barcelona · ESUniversity of Calgary · CA

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR-1095Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR-1408CHDI Foundation A-14079Comunidad de Madrid AvanCell-CM; S2017/BMD3692Generalitat de Catalunya ADVANCE(CAT)Instituto de Salud Carlos III CIBERNEDInstituto de Salud Carlos III RD16/0011/0011Instituto de Salud Carlos III RD16/0011/0012Medical Research Council MR/L023784/1Medical Research Council MR/L023784/2Ministerio de Ciencia, Innovación y Universidades RTI2018-099001-B-I00Ministerio de Ciencia, Innovación y Universidades SAF2017-84248-PMinisterio de Ciencia, Innovación y Universidades (ES) FIS2016-78507-C2-2-PMinisterio de Ciencia, Innovación y Universidades (ES) SAF 2017-88076-R
6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) are a powerful tool for modelling human development. In recent years, hPSCs have become central in cell-based therapies for neurodegenerative diseases given their potential to replace affected neurons. However, directing hPSCs into specific neuronal types is complex and requires an accurate protocol that mimics endogenous neuronal development. Here we describe step-by-step a fast feeder-free neuronal differentiation protocol to direct hPSCs to mature forebrain neurons in 37 days in vitro (DIV). The protocol is based upon a combination of specific morphogens, trophic and growth factors, ions, neurotransmitters and extracellular matrix elements. A human-induced PSC line (Ctr-Q33) and a human embryonic stem cell line (GEN-Q18) were used to reinforce the potential of the protocol. Neuronal activity was analysed by single-cell calcium imaging. At 8 DIV, we obtained a homogeneous population of hPSC-derived neuroectodermal progenitors which self-arranged in bi-dimensional neural tube-like structures. At 16 DIV, we generated hPSC-derived neural progenitor cells (NPCs) with mostly a subpallial identity along with a subpopulation of pallial NPCs. Terminal in vitro neuronal differentiation was confirmed by the expression of microtubule associated protein 2b (Map 2b) by almost 100% of hPSC-derived neurons and the expression of specific-striatal neuronal markers including GABA, CTIP2 and DARPP-32. HPSC-derived neurons showed mature and functional phenotypes as they expressed synaptic markers, voltage-gated ion channels and neurotransmitter receptors. Neurons displayed diverse spontaneous activity patterns that were classified into three major groups, namely "high", "intermediate" and "low" firing neurons. Finally, transplantation experiments showed that the NPCs survived and differentiated within mouse striatum for at least 3 months. NPCs integrated host environmental cues and differentiated into striatal medium-sized spiny neurons (MSNs), which successfully integrated into the endogenous circuitry without teratoma formation. Altogether, these findings demonstrate the potential of this robust human neuronal differentiation protocol, which will bring new opportunities for the study of human neurodevelopment and neurodegeneration, and will open new avenues in cell-based therapies, pharmacological studies and alternative in vitro toxicology.

Indexed as

AnimalsCell Culture TechniquesCell LineCorpus StriatumHumansMiceNeurogenesisNeuronsPluripotent Stem CellsCalcium imagingNeuronal differentiationSpike-inference analysisStriatumTelencephalonTransplantation

Identifiers

PMID32356172
PMCPMC7253531
OpenAlexW3022428923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.